β¨ Medicines and Electricity Notices
NEW ZEALAND GAZETTE, No. 148 β 11 DECEMBER 2014
Note: This consent is given subject to the following condition:
Rilutek can only be prescribed by specialist physicians who care for patients with Motor Neurone Disease, neurologists and palliative care physicians.
Note: This renewed consent is valid for two years from 4 April 2015.
Product: Verorab
Active Ingredient: Rabies vaccine, Wistar PM/WI 38-1503-3M 2.5IU
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Sanofi Pasteur SA, Val-De-Reuil Cedex, France
Sanofi Pasteur SA, Marcy LβEtoile, France
Catalent Belgium SA, Brussels, Belgium
Note: This renewed consent is valid for two years from 27 January 2015.
Dated this 3rd day of December 2014.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2014-go7510
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Emtriva
Active Ingredient: Emtricitabine 200mg
Dosage Form: Capsule
New Zealand Sponsor: Gilead Sciences (NZ)
Manufacturers: Abbott Laboratories Inc, Illinois, United States of America
Excella GmbH, Feucht, Germany
Product: Synacthen
Active Ingredient: Tetracosactide 0.25mg/mL equivalent to Tetracosactide hexaacetate 0.28mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Takeda Austria GmbH, Linz, Austria
Product: Synacthen Depot
Active Ingredient: Tetracosactide 1mg/mL equivalent to Tetracosactide hexaacetate 1.12mg/mL
Dosage Form: Injection (depot)
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Takeda Austria GmbH, Linz, Austria
Dated this 3rd day of December 2014.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2014-go7509
Declaration of OtagoNet as an Electricity Operator
Pursuant to section 4 of the Electricity Act 1992, I hereby declare
Last Tango Limited and Pylon Limited, together trading as OtagoNet Limited
to be electricity operators for the purposes of section 24 of the Electricity Act 1992.
Dated at Wellington this 1st day of December 2014.
Hon SIMON BRIDGES, Minister of Energy and Resources.
2014-go7487
53
Next Page →
β¨ LLM interpretation of page content
π₯
Renewal of Provisional Consent to the Distribution of Medicines
(continued from previous page)
π₯ Health & Social WelfareMedicines, Provisional Consent, Renewal, Rilutek
π₯ Renewal of Provisional Consent to the Distribution of Verorab
π₯ Health & Social Welfare3 December 2014
Medicines, Provisional Consent, Renewal, Verorab, Rabies vaccine
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare3 December 2014
Medicines, Consent, Distribution, Emtriva, Synacthen, Synacthen Depot
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
ποΈ Declaration of OtagoNet as an Electricity Operator
ποΈ Infrastructure & Public Works1 December 2014
Electricity, Operator, Declaration, OtagoNet
- Hon SIMON BRIDGES, Minister of Energy and Resources
NZ Gazette 2014, No 148